FDA Warning Letter — Reine Lifescience
The FDA took a Warning Letter action against Reine Lifescience on May 9, 2018 (Ankleshwar, India). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Reine Lifescience
- Date
- May 9, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Ankleshwar (India)